Effect of Tenofovir on Genital HSV Shedding: a Randomized, Double-blind, Placebo-controlled Clinical Trial.

Trial Profile

Effect of Tenofovir on Genital HSV Shedding: a Randomized, Double-blind, Placebo-controlled Clinical Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Jan 2016

At a glance

  • Drugs Tenofovir (Primary) ; Tenofovir disoproxil fumarate (Primary)
  • Indications Herpes simplex virus type 2 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2014 Planned End Date changed from 1 Dec 2013 to 1 Jun 2015 as reported by ClinicalTrials.gov.
    • 04 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 02 Mar 2012 New source identified and integrated (41250A; University of Washington Health Sciences).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top